Arcellx Inc

NASDAQ:ACLX   4:00:00 PM EDT
69.55
-0.90 (-1.28%)
4:38:04 PM EDT: $68.22 -1.33 (-1.91%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.64B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$21.47 Million
Adjusted EPS-$0.50
See more estimates
10-Day MA$70.23
50-Day MA$65.35
200-Day MA$46.62
See more pivots

Arcellx Inc Stock, NASDAQ:ACLX

25 West Watkins Mill Road, Suite A, Gaithersburg, Maryland 20878
United States of America
Phone: +1.240.327.0603
Number of Employees: 130

Description

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.